EP1690558A1 — Device for treatment of diabetic disorders
Assigned to Nolabs AB · Expires 2006-08-16 · 20y expired
What this patent protects
A device is provided that allows for target treatment of neuropathy, such as diabetic peripheral neuropathy or ulcers, vaso-constrictive disorders, macro-angiopathy and slow healing wounds as consequence of diabetic neuropathy. The device comprises a nitric oxide (NO) eluting pol…
USPTO Abstract
A device is provided that allows for target treatment of neuropathy, such as diabetic peripheral neuropathy or ulcers, vaso-constrictive disorders, macro-angiopathy and slow healing wounds as consequence of diabetic neuropathy. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the infected area, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.